Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

NHS test and trace system ‘still not good enough’ says health leader

Test and trace system falls short in latest figures

- PMLiVE

Mearns & Pike, Electric Putty and Evoke KYNE make a clean sweep at Communiqué 2020

Respective projects for Crohn’s and Colitis UK win across the board

- PMLiVE

Q&A: Kate Callan

What gets you out of bed in the morning?My four-year-old is notorious for climbing into bed for morning snuggles as soon as the sun rises. If I managed to sleep...

- PMLiVE

Step forward for health charities

The repercussions of COVID-19 will continue to have an impact long after some form of normality returns

- PMLiVE

The search for treatments for Parkinson’s disease

The research requires resilience but pharma is urged to ‘keep innovating, keep trying’

- PMLiVE

Communiqué Awards 2020

Watch the event live from 4pm today – join us at pmlive.com/cxhealth

- PMLiVE

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

Study will evaluate experimental anti-inflammatory drug

- PMLiVE

Pfizer jumps on early data from BioNTech-partnered COVID-19 vaccine study

Preliminary data demonstrates promising immunogenicity

- PMLiVE

Homesick

You thought getting people to stay at home was hard – getting them to leave home might be harder

- PMLiVE

Azafaros expands executive team with three senior hires

Kyle Landskroner, Ruben Giorgino and Louise Kooij join the team

- PMLiVE

Margot Hannah, OPEN Health – A personal perspective of LGBT+ and diversity.

Ditch the Label – it’s just me.

OPEN Health

The impact of COVID-19 on clinical trials

As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links